Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

0.5765
-0.0283-4.68%
Volume:1.42M
Turnover:822.13K
Market Cap:160.27M
PE:-1.16
High:0.6098
Open:0.6098
Low:0.5610
Close:0.6048
52wk High:2.55
52wk Low:0.5261
Shares:278.00M
Float Shares:245.00M
Volume Ratio:0.36
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4975
EPS(LYR):-0.2582
ROE:-547.87%
ROA:-49.87%
PB:5.13
PE(LYR):-2.23

Loading ...

Humacyte Faces Nasdaq Non-Compliance Warning as Share Price Risks Delisting and Future Capital Constraints

TIPRANKS
·
Aug 14

U.S. Stocks on the MOVE-Sutro Biopharma, Humacyte

Reuters
·
Aug 13

Humacyte Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 12

Humacyte Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Humacyte Q2 Net Loss Widens on Inventory, Production Costs

Reuters
·
Aug 12

Humacyte Q2 EPS $(0.16) Misses $(0.10) Estimate, Sales $406.000K Miss $1.116M Estimate

Benzinga Earnings
·
Aug 12

Humacyte Q2 Cash & Investments USD 80.3 Million

THOMSON REUTERS
·
Aug 12

Humacyte Q2 Basic EPS USD -0.16

THOMSON REUTERS
·
Aug 12

Humacyte Q2 Operating Expenses USD 27.402 Million

THOMSON REUTERS
·
Aug 12

Humacyte Q2 Revenue USD 406 Thousand VS. Ibes Estimate USD 1.12 Million

THOMSON REUTERS
·
Aug 12

Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 12

Humacyte Inc Expected to Post a Loss of 10 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Humacyte Inc Expected to Post a Loss of 10 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Humacyte Updates Financial Calendar, Sets Quarterly Results Webcast and Call

Reuters
·
Aug 07

Humacyte Gets NASDAQ Notice After Shares Trade Below $1 Bid-price Minimum

Reuters
·
Aug 01

Humacyte Price Target Maintained with a $2.00/Share by BTIG

Dow Jones
·
Jul 29

Humacyte Says FDA Accepts IND for First-in-human CTEV CABG Study

Reuters
·
Jul 27

Humacyte Announces FDA Acceptance of Ind for First-in-Human Clinical Study of Ctev for Coronary Artery Bypass Grafting

THOMSON REUTERS
·
Jul 27

Humacyte - to Initiate Phase 2a Ctev Study in Cabg This Quarter

THOMSON REUTERS
·
Jul 27

Humacyte Names Nephrologists Kossmann, Roy-chaudhury as Dialysis Access Advisors

Reuters
·
Jul 14